opendata.bot
Company number
06970743

CELL THERAPY LIMITED

Active
✓ Active company on the official register. Next accounts due 31 December 2026.

Company details

Registered name
CELL THERAPY LIMITED
Company number
06970743
Registered office
CELIXIR HOUSE STRATFORD-UPON-AVON BUSINESS AND TECHNOLOGY PARK, INNOVATION WAY, STRATFORD-UPON-AVON, CV37 7GZ, ENGLAND
Company type
Private Limited Company
Incorporated on
23 July 2009
Status
Active
Age
17 years
Nature of business (SIC)
72190 — Other research and experimental development on natural sciences and engineering
Accounts — next due
31 Dec 2026
Accounts — last made up to
31 Mar 2025
Confirmation statement — next due
13 Mar 2027
Confirmation statement — last
27 Feb 2026

What the register says

Facts from the register, with the dates they are filed under. Not a score: what they mean is for you to judge, and every line can be checked against Companies House itself.

Companies House register snapshot, read 02/09/2026.

People with significant control

Beneficial owners holding over 25% of shares, voting rights or the right to appoint directors

Cardiogeni Plc
has significant influence or control · has significant influence or control (through a firm)
Notified 06/01/2025
Celixir Limited
owns 75–100% of shares · holds 75–100% of voting rights · can appoint and remove directors
Notified 12/04/2017
Dr Mubasher Shiekh
owns 25–50% of shares · holds 25–50% of voting rights
Notified 06/04/2016
Sir Martin John Evans
owns 25–50% of shares · holds 25–50% of voting rights
Notified 06/04/2016
Trevor Ajan Reginald
owns 25–50% of shares · holds 25–50% of voting rights
Notified 06/04/2016

Corporate structure

Who controls this company, and who they control in turn

5 controllers Drag to move · scroll to zoom · double-click to expand
Company Person Current control Ended

Connections

Corporate owner has significant influence or control · has significant influence or control Notified 06/01/2025 Controls 6 companies
Corporate owner owns 75–100% of shares · holds 75–100% of votes · can appoint and remove directors Control ended 06/01/2025 Controls 6 companies
Dr Mubasher Shiekh
born 02/1971 · England owns 25–50% of shares · holds 25–50% of votes Control ended 12/04/2017
Sir Martin John Evans
born 01/1941 · Wales owns 25–50% of shares · holds 25–50% of votes Control ended 12/04/2017 Controls 3 companies
Trevor Ajan Reginald
born 02/1972 · England owns 25–50% of shares · holds 25–50% of votes Control ended 12/04/2017

Change history

Reconstructed from the dated records Companies House publishes

DateChangeWasNow
06/01/2025 Person with significant control ceased Celixir Limited
06/01/2025 Person with significant control added Cardiogeni Plc
12/04/2017 Person with significant control ceased Trevor Ajan Reginald
12/04/2017 Person with significant control ceased Sir Martin John Evans
12/04/2017 Person with significant control ceased Dr Mubasher Shiekh
12/04/2017 Person with significant control added Celixir Limited
06/04/2016 Person with significant control added Trevor Ajan Reginald
06/04/2016 Person with significant control added Sir Martin John Evans
06/04/2016 Person with significant control added Dr Mubasher Shiekh

Financial highlights

Parsed from the filed statutory accounts (£ thousands, except employees)

Source: Companies House bulk data filed accounts (iXBRL)
Metric FY2025FY2024
Total assets less current liabilities -3,711 -3,558
Net assets -3,779 -10,683
Employees (avg) 2 2

Documents for CELL THERAPY LIMITED

Need this one company on file? Buy the document on its own — no plan required.

Company extract£1.99

The full registration record as held today — name, number, status, registered office, company type, previous names, officers, PSC and SIC codes, timestamped for your file.

PDF Order
Financial statements£3.99

Every figure the company’s own accounts state, across each filed period, with year-on-year movement. Most UK companies file small or micro-entity accounts — a balance sheet and a headcount, no turnover or profit.

PDF + CSV Order
Ownership report£3.99

Who controls the company: persons with significant control, the nature of that control, the ownership graph and every other company those controllers hold.

PDF Order

Data protection register

Registered with the Information Commissioner's Office as a data protection fee payer.

Cell Therapy Limited — CF14 7YT
Tier 1 · renews 12/10/2026
ICO entry

The ICO publishes no company number, so this is matched on the registered name . Check the ICO entry before relying on it.

Get this company via API

Every field on this page is available as structured JSON behind one endpoint and one API key.

GET /v1/company/gb/06970743
X-Api-Key: $OPENDATA_KEY
Read the API docs

Frequently asked questions

What is the company number of CELL THERAPY LIMITED?
According to the official registry, the company number of CELL THERAPY LIMITED is 06970743.
Where is CELL THERAPY LIMITED registered?
The registered office is CELIXIR HOUSE STRATFORD-UPON-AVON BUSINESS AND TECHNOLOGY PARK, INNOVATION WAY, STRATFORD-UPON-AVON, CV37 7GZ, ENGLAND.
What is the SIC code of CELL THERAPY LIMITED?
The nature of business is recorded under SIC code 72190 — Other research and experimental development on natural sciences and engineering.
Who controls CELL THERAPY LIMITED?
Cardiogeni Plc is recorded as a person with significant control, and has significant influence or control, has significant influence or control (through a firm).
When are the next accounts of CELL THERAPY LIMITED due?
The next annual accounts are due by 31 December 2026, and the last accounts were made up to 31 March 2025.

About CELL THERAPY LIMITED (06970743)

CELL THERAPY LIMITED is a private limited company incorporated on 23 July 2009 and registered in the United Kingdom under company number 06970743. Its registered office is at CELIXIR HOUSE STRATFORD-UPON-AVON BUSINESS AND TECHNOLOGY PARK, INNOVATION WAY, STRATFORD-UPON-AVON, CV37 7GZ, ENGLAND. The recorded nature of business is other research and experimental development on natural sciences and engineering (SIC 72190). The company is currently active , with statutory accounts last made up to 31 March 2025. , and the person with significant control is Cardiogeni Plc. This profile is provided by opendata.bot by Noetikos, aggregating official data from Companies House bulk data , last refreshed 2 September 2026.

Other research and experimental development on natural sciences and engineering across UK registers

The same sector and the same company, seen through every register we hold

Explore by sector

Every UK company records what it does as a SIC code — browse the sectors around this one.